CNXU Analyst Ratings
Conexeu Sciences Inc. (CNXU) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $88.6M, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.51 to the broader market. Conexeu Sciences Inc. Led by Miles Harrison, public since 2026-05-21.
Analyst Ratings
In the September 2026 monthly count, 1 analyst rated CNXU: 0 Strong Buy, 1 Buy, 0 Hold, 0 Sell and 0 Strong Sell.
Price Targets
- Average Target
- $20.00
- Median Target
- $20.00
- High
- $20.00
- Low
- $20.00
- Targets Published, Last 12 Months
- 1
Recent Price Targets
The 1 most recent of at least 1 price targets published in the last 12 months.
| Date | Firm | Analyst | Target | Price When Posted |
|---|---|---|---|---|
| Jun 22, 2026 | H.C. Wainwright | Not named | $20.00 | $13.28 |
How to Read CNXU Analyst Coverage
Sell-side equity analysts publish three primary outputs: ratings (Strong Buy / Buy / Hold / Sell / Strong Sell, or firm-specific equivalents), price targets, and EPS / revenue estimate revisions. Rating consensus moves slowly relative to price; it reflects 12-month directional conviction rather than near-term momentum. Price targets are more responsive but typically drift behind realized price during sharp moves. The most actionable signal for options traders is a cluster of ratings actions across multiple firms within a short window, which compresses or expands implied volatility on a horizon of days to weeks and shifts the put-call skew toward the directional consensus. The recent-actions table above shows the five most recent firm-level changes; longer histories live behind aggregator sources.
For event-driven options sizing, pair the consensus rating and target distribution with the implied-volatility surface and dealer-positioning view. Aggressive target hikes from multiple firms tend to tighten put skew (downside protection becomes relatively cheaper); aggressive cuts widen put skew. The size of the IV response in the hours after a rating change is visible on the per-ticker volatility skew page and the gamma-exposure page, both of which show how dealer hedging propagates the analyst-driven flow into the listed options chain.
Learn how analyst ratings is reported and how to read the data →
Frequently asked CNXU analyst ratings questions
- What is the CNXU consensus price target?
- As of the latest aggregator update, Conexeu Sciences Inc. (CNXU) carries a consensus 12-month price target of $20.00. Target ranges run from a low of $20.00 to a high of $20.00. The target is the average of the price targets published by sell-side equity analysts covering the name.
- What is the analyst rating consensus on CNXU?
- In the September 2026 monthly count, 1 analysts rated CNXU, and the distribution tilts to the Buy side: 0 Strong Buy, 1 Buy, 0 Hold, 0 Sell and 0 Strong Sell. Rating consensus moves slowly relative to price; it reflects sell-side conviction over a 12-month horizon rather than near-term momentum.
- What recent ratings actions has CNXU seen?
- Recent ratings actions for CNXU are not currently in the snapshot.
- How do analyst targets affect CNXU options pricing?
- Analyst target revisions tend to be priced in by the lit options market within minutes of publication, but persistent target drift over weeks does correlate with implied-volatility movement. Aggressive target hikes from multiple firms inside a single quarter tighten put skew (downside protection becomes cheaper relative to upside speculation); aggressive cuts widen put skew. The most actionable read is the implied-vol response in the hours after a target change, which is visible on the per-ticker volatility skew page.